The past decade has witnessed significant transformations in healthcare infrastructure, driven by the widespread adoption of technology and innovative medical devices. With the rising prevalence of infectious and chronic diseases, the demand for disinfection and sterilization equipment has reached a critical level. The urgency to effectively combat these diseases has underscored the importance of advanced equipment for disinfection and sterilization, highlighting their indispensable role in modern healthcare practices.
According to Data Bridge Market Research, the Hospital Acquired Infection Control Market accounted for USD 29.1 billion in 2021 and is expected to reach USD 34.10 billion by 2029. The market is expected to grow with a CAGR of 9.90% in the forecast period of 2022 to 2029.
“Rise in the prevalence of hospital-acquired infections (HAIs) propelling the market’s growth”
The rise in hospital-acquired infections is attributed to inadequate preventive measures. Contamination of medical equipment and devices remains a significant cause of infections in healthcare settings. Consequently, there will be an escalated demand for the hospital-acquired infection control market. The need to address this pressing issue drives the growth of measures and solutions to prevent and control infections acquired within hospitals.
What restraints the growth of the hospital acquired infection control market?
“Increased cost of endoscopy reprocessing restraints the market’s growth”
The hospital acquired infection control market is facing constraints in its growth due to the increased cost of endoscopy reprocessing. As hospitals strive to implement stringent infection control measures, the expenses associated with reprocessing endoscopic equipment have risen significantly. These elevated costs pose a challenge to healthcare facilities, impacting their ability to invest in comprehensive infection control solutions. Therefore, the increased financial burden limits the market's expansion
Segmentation: Hospital Acquired Infection Control Market
The hospital acquired infection control market is segmented on the basis of product, application, technology, disease and end users.
- On the basis of product, the hospital acquired infection control market has been segmented into sterilizers, disinfectors, endoscope reprocessors, microbial testing instruments, reagents, consumables, disinfectants, infection prevention and surveillance software, and others.
- On the basis of application, the hospital acquired infection control market has been segmented into disease testing, and drug-resistance testing.
- On the basis of technology, the hospital acquired infection control market has been segmented into phenotypic methods, and genotypic methods.
- On the basis disease, the hospital acquired infection control market has been segmented into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infection, and others.
- On the end users, the hospital acquired infection control market has been segmented into hospitals, ICUs, ambulatory surgical, diagnostic centers, nursing homes, maternity centers, and others.
Regional Insights: North America dominates the hospital acquired infection control market
North America dominates the hospital acquired infection control market due to the rise in major healthcare facilities and authorities focusing on preventing and containing infections from various healthcare settings. Additionally, the increasing awareness of hospital-acquired infections among the public will contribute to the market's expansion in the region throughout the forecast period.
Asia-Pacific is projected to observe significant amount of growth in the hospital acquired infection control market owing to the surge in the incidence of hospital acquired infections in low and middle-income countries, coinciding with the advancement of healthcare infrastructure. Secondly, newborns in these advancing countries face a greater risk of contracting healthcare-associated infections compared to developed countries. These factors combined are projected to drive the growth of the region's hospital acquired infection control market in the forthcoming years.
To know more about the study visit, https://www.databridgemarketresearch.com/de/reports/global-hospital-acquired-infection-control-market
Recent Development
- In September 2021, Sodexo expanded its partnership with Ecolab in the United States to control hospital-acquired infections through the Protecta Plus programme. This programme was created to reduce infection risk in hospitals and healthcare facilities by utilising Ecolab's Bioquell hydrogen peroxide vapour technology.
The Prominent Key Players Operating in the Hospital Acquired Infection Control Market Include:
- Olympus Corporation (Japan)
- Cantel Medical (U.S.)
- Getinge AB (Sweden)
- STERIS plc (U.S.)
- Belimed (Switzerland)
- STEELCO S.p.A. (Italy)
- ASP (U.S.)
- BD (U.S.)
- Crosstex International, Inc. (U.S.)
- Diversey, Inc (U.S.)
- MMM Group (U.S.)
- 3M (U..S)
- bioMérieux SA (France)
- Sterigenics U.S., LLC (U.S.)
- Cepheid (U.S.)
- Dentsply Sirona (U.S.)
- Mindray Bio-Medical Electronics Co., Ltd (China)
- Randox Laboratories Ltd. (U.K.)
- Ortho Clinical Diagnostics (U.S.)
- Nova Biomedical (U.K.)
- Sysmex Corporation (Japan)
Above are the key players covered in the report, to know about more and exhaustive list of hospital acquired infection control market companies contact, https://www.databridgemarketresearch.com/de/contact
Research Methodology: Global Hospital Acquired Infection Control Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
